BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16550001)

  • 1. Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.
    Annabi B; Bouzeghrane M; Currie JC; Dulude H; Daigneault L; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Anticancer Drugs; 2006 Apr; 17(4):429-38. PubMed ID: 16550001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A PSP94-derived peptide PCK3145 inhibits MMP-9 secretion and triggers CD44 cell surface shedding: implication in tumor metastasis.
    Annabi B; Bouzeghrane M; Currie JC; Hawkins R; Dulude H; Daigneault L; Ruiz M; Wisniewski J; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Clin Exp Metastasis; 2005; 22(5):429-39. PubMed ID: 16283486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding.
    Annabi B; Currie JC; Bouzeghrane M; Dulude H; Daigneault L; Garde S; Rabbani SA; Panchal C; Wu JJ; Béliveau R
    Biochem Biophys Res Commun; 2006 Jul; 346(1):358-66. PubMed ID: 16759641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis.
    Lamy S; Ruiz MT; Wisniewski J; Garde S; Rabbani SA; Panchal C; Wu JJ; Annabi B
    Int J Cancer; 2006 May; 118(9):2350-8. PubMed ID: 16331603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PCK3145 inhibits proliferation and induces apoptosis in breast and colon cancer cells.
    Kostopoulos A; Papageorgiou E; Koutsilieris M; Sivolapenko G
    Anticancer Res; 2015 Mar; 35(3):1377-84. PubMed ID: 25750288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate secretory protein of 94 amino acids (PSP-94) and its peptide (PCK3145) as potential therapeutic modalities for prostate cancer.
    Shukeir N; Garde S; Wu JJ; Panchal C; Rabbani SA
    Anticancer Drugs; 2005 Nov; 16(10):1045-51. PubMed ID: 16222145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic 15-mer peptide (PCK3145) derived from prostate secretory protein can reduce tumor growth, experimental skeletal metastases, and malignancy-associated hypercalcemia.
    Shukeir N; Arakelian A; Chen G; Garde S; Ruiz M; Panchal C; Rabbani SA
    Cancer Res; 2004 Aug; 64(15):5370-7. PubMed ID: 15289344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PSP94 contributes to chemoresistance and its peptide derivative PCK3145 represses tumor growth in ovarian cancer.
    Yan BX; Ma JX; Zhang J; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Oncogene; 2014 Nov; 33(45):5288-94. PubMed ID: 24186202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and tolerability of PCK3145, a synthetic peptide derived from prostate secretory protein 94 (PSP94) in metastatic hormone-refractory prostate cancer.
    Hawkins RE; Daigneault L; Cowan R; Griffiths R; Panchal C; Armstrong A; Fenemore J; Irvine A; Sereda K; Dulude H
    Clin Prostate Cancer; 2005 Sep; 4(2):91-9. PubMed ID: 16197609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg.
    Annabi B; Currie JC; Moghrabi A; Béliveau R
    Leuk Res; 2007 Sep; 31(9):1277-84. PubMed ID: 17081606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SIKVAV, a laminin alpha1-derived peptide, interacts with integrins and increases protease activity of a human salivary gland adenoid cystic carcinoma cell line through the ERK 1/2 signaling pathway.
    Freitas VM; Vilas-Boas VF; Pimenta DC; Loureiro V; Juliano MA; Carvalho MR; Pinheiro JJ; Camargo AC; Moriscot AS; Hoffman MP; Jaeger RG
    Am J Pathol; 2007 Jul; 171(1):124-38. PubMed ID: 17591960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adhesion and protease activity in cell lines from human salivary gland tumors are regulated by the laminin-derived peptide AG73, syndecan-1 and beta1 integrin.
    Gama-de-Souza LN; Cyreno-Oliveira E; Freitas VM; Melo ES; Vilas-Boas VF; Moriscot AS; Jaeger RG
    Matrix Biol; 2008 Jun; 27(5):402-19. PubMed ID: 18378436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
    Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
    Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Culture of human fibrosarcoma HT-1080 cells in presence of fibronectin activates MMP-2.
    Chakrabarti J; Mitra A; Banerji A; Chatterjee A
    J Environ Pathol Toxicol Oncol; 2006; 25(4):667-77. PubMed ID: 17341207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor.
    Givant-Horwitz V; Davidson B; Reich R
    Cancer Res; 2004 May; 64(10):3572-9. PubMed ID: 15150114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGF-induced trophoblast secretion of MMP-9 and TIMP-1 involves activation of both PI3K and MAPK signalling pathways.
    Qiu Q; Yang M; Tsang BK; Gruslin A
    Reproduction; 2004 Sep; 128(3):355-63. PubMed ID: 15333786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a UHPLC-UV method for the determination of a prostate secretory protein 94-derived synthetic peptide (PCK3145) in human plasma and assessment of its stability in human plasma.
    El Mubarak MA; Leontari I; Danika C; Katsila T; Sivolapenko G
    Biomed Chromatogr; 2016 Sep; 30(9):1476-80. PubMed ID: 26892539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levosimendan inhibits interleukin-1β-induced cell migration and MMP-9 secretion in rat cardiac fibroblasts.
    Okada M; Suzuki A; Yamawaki H; Hara Y
    Eur J Pharmacol; 2013 Oct; 718(1-3):332-9. PubMed ID: 24012928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.